incretin and glp-1 Hormones Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches Incretin-based therapy of metabolic disease

Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake

Other NASH-related biomarkers were decreased, and adiponectin was increased in patients with T2DM [62]

Because our carb and fat intake has increased so much relative to carbohydrates, our overall percentage of total calories from protein (i.e., protein %) has decreased

The most reported issues are increased nausea, vomiting, indigestion, and acid reflux

Lighter individuals may experience stronger effects (and more side effects) at each dose level, while heavier individuals may need the full 12mg maintenance dose to achieve optimal results

"A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity." European Journal of Clinical Pharmacology 80.5 (2024): 669-676